Fliar explore / investors

Investors in Cambridge.

This directory brings together 113 investor pages in Cambridge on Fliar. That is 94 investor lists, 8 angel lists and 11 investor profiles. The list with the most capital behind it is Life Sciences investors in Cambridge ($327.2B across the rounds it covers).

In this directory113investor pages
94 sectors

113 pages

Investor listLife Sciences investors in CambridgeLife Sciences · Cambridge, United States1,421 investors499 companies$327.2B in roundsInvestor listBiopharmaceuticals investors in CambridgeBiopharmaceuticals · Cambridge, United States904 investors307 companies$218.4B in roundsInvestor listOncology investors in CambridgeOncology · Cambridge, United States644 investors165 companies$151.8B in roundsInvestor listGenomics investors in CambridgeGenomics · Cambridge, United States504 investors107 companies$98B in roundsInvestor listImmunotherapy investors in CambridgeImmunotherapy · Cambridge, United States369 investors83 companies$67.1B in roundsInvestor listHealthTech investors in CambridgeHealthTech · Cambridge, United States667 investors153 companies$45.4B in roundsInvestor listImmunology investors in CambridgeImmunology · Cambridge, United States226 investors46 companies$39.2B in roundsInvestor listLife Sciences Tech investors in CambridgeLife Sciences Tech · Cambridge, United States339 investors57 companies$37.1B in roundsInvestor listArtificial Intelligence investors in CambridgeArtificial Intelligence · Cambridge, United States446 investors63 companies$35.1B in roundsInvestor listGene Therapy investors in CambridgeGene Therapy · Cambridge, United States135 investors28 companies$32.1B in roundsInvestor listCancer Immunotherapy investors in CambridgeCancer Immunotherapy · Cambridge, United States215 investors34 companies$30.2B in roundsInvestor listAntibody Based Immunotherapy investors in CambridgeAntibody Based Immunotherapy · Cambridge, United States228 investors39 companies$26.1B in roundsInvestor listNeurology investors in CambridgeNeurology · Cambridge, United States303 investors68 companies$25.7B in roundsInvestor listRare Diseases investors in CambridgeRare Diseases · Cambridge, United States182 investors36 companies$25.1B in roundsInvestor listNative AI in Healthcare investors in CambridgeNative AI in Healthcare · Cambridge, United States158 investors16 companies$22.3B in roundsInvestor listNative AI in Life Sciences investors in CambridgeNative AI in Life Sciences · Cambridge, United States125 investors12 companies$22B in roundsInvestor listCheminformatics for Drug Discovery investors in CambridgeCheminformatics for Drug Discovery · Cambridge, United States148 investors14 companies$21.8B in roundsInvestor listLife Sciences Platforms and Tools investors in CambridgeLife Sciences Platforms and Tools · Cambridge, United States255 investors59 companies$20.1B in roundsInvestor listInfectious Diseases investors in CambridgeInfectious Diseases · Cambridge, United States137 investors25 companies$19.8B in roundsInvestor listMedical Devices investors in CambridgeMedical Devices · Cambridge, United States221 investors55 companies$18.5B in roundsInvestor listAI Drug Discovery investors in CambridgeAI Drug Discovery · Cambridge, United States104 investors8 companies$18.1B in roundsInvestor listGenerative AI investors in CambridgeGenerative AI · Cambridge, United States102 investors9 companies$16.4B in roundsInvestor listClinical Genomics investors in CambridgeClinical Genomics · Cambridge, United States126 investors23 companies$15.8B in roundsInvestor listGene Editing investors in CambridgeGene Editing · Cambridge, United States80 investors9 companies$15B in roundsInvestor listCell Therapy investors in CambridgeCell Therapy · Cambridge, United States106 investors19 companies$14.1B in roundsInvestor listNeurodegenerative Diseases Drugs investors in CambridgeNeurodegenerative Diseases Drugs · Cambridge, United States152 investors31 companies$11.8B in roundsInvestor listAdoptive T Cell Therapy investors in CambridgeAdoptive T Cell Therapy · Cambridge, United States95 investors16 companies$11.7B in roundsInvestor listHealthTech SaaS investors in CambridgeHealthTech SaaS · Cambridge, United States233 investors37 companies$10.2B in roundsInvestor listPrecision Medicine investors in CambridgePrecision Medicine · Cambridge, United States75 investors12 companies$8.7B in roundsInvestor listDiversified Pharmaceuticals investors in CambridgeDiversified Pharmaceuticals · Cambridge, United States84 investors17 companies$8.1B in roundsInvestor listHealthcare IT investors in CambridgeHealthcare IT · Cambridge, United States251 investors60 companies$7.8B in roundsInvestor listIn Vitro Diagnostics investors in CambridgeIn Vitro Diagnostics · Cambridge, United States134 investors29 companies$7.6B in roundsInvestor listRare Metabolic Diseases Drugs investors in CambridgeRare Metabolic Diseases Drugs · Cambridge, United States65 investors11 companies$7.4B in roundsInvestor listMetabolic Diseases investors in CambridgeMetabolic Diseases · Cambridge, United States53 investors12 companies$7.4B in roundsInvestor listAI as a Service investors in CambridgeAI as a Service · Cambridge, United States106 investors16 companies$7.3B in roundsInvestor listImmunotherapeutic Vaccines investors in CambridgeImmunotherapeutic Vaccines · Cambridge, United States54 investors9 companies$6.7B in roundsInvestor listFinTech investors in CambridgeFinTech · Cambridge, United States189 investors43 companies$6.4B in roundsInvestor listMicrobiome Therapeutics investors in CambridgeMicrobiome Therapeutics · Cambridge, United States73 investors8 companies$5.4B in roundsInvestor listDrug Delivery investors in CambridgeDrug Delivery · Cambridge, United States88 investors15 companies$5.3B in roundsInvestor listCybersecurity investors in CambridgeCybersecurity · Cambridge, United States116 investors24 companies$5.2B in roundsInvestor listIndustry 4.0 investors in CambridgeIndustry 4.0 · Cambridge, United States130 investors24 companies$5.1B in roundsInvestor listNative AI in Software Development investors in CambridgeNative AI in Software Development · Cambridge, United States90 investors11 companies$5.1B in roundsInvestor listAI Infrastructure investors in CambridgeAI Infrastructure · Cambridge, United States106 investors14 companies$4.8B in roundsInvestor listNanotechnology investors in CambridgeNanotechnology · Cambridge, United States69 investors12 companies$4.4B in roundsInvestor listCardiac and Vascular Disorders investors in CambridgeCardiac and Vascular Disorders · Cambridge, United States68 investors16 companies$4.4B in roundsInvestor listAgriTech investors in CambridgeAgriTech · Cambridge, United States84 investors20 companies$4.3B in roundsInvestor listB2B AgriTech investors in CambridgeB2B AgriTech · Cambridge, United States83 investors19 companies$4.3B in roundsInvestor listCrop Tech investors in CambridgeCrop Tech · Cambridge, United States67 investors18 companies$4.3B in rounds
About this directory page

Investors in Cambridge

This directory brings together 113 investor pages in Cambridge on Fliar. That is 94 investor lists, 8 angel lists and 11 investor profiles. The list with the most capital behind it is Life Sciences investors in Cambridge ($327.2B across the rounds it covers).

Sectors with the most pages in Cambridge are Life Sciences (2), Biopharmaceuticals (2), HealthTech (2), Genomics (2), Artificial Intelligence (2) and Life Sciences Platforms and Tools (2). 94 sectors are covered here in total.

Also on Fliar: Company lists in Cambridge (58).

Same market, other page types
All sectors in Cambridge A–Z 94
All locations A–Z 589